Exentis Group AG, a leading provider of industrial 3D manufacturing solutions, reports significant success in the US market. In the fourth quarter of 2024, the company received orders for the delivery of a total of nine 3D production systems. The total volume of these orders amounts to around 20 million Swiss francs.
The Chief Commercial Officer of Exentis Group AG, Gürsel Demircali, emphasized the importance of these developments: “These orders are a decisive milestone in the development of the USA as the world’s most important market for additive manufacturing. Our technology platform is increasingly establishing itself as the preferred solution for the production of ultra-fine industrial components and pharmaceutical products.”
The Exentis technology enables industrial high-volume production with a free choice of materials, including metals, ceramics and polymers, as well as specific applications in bioprinting. The process is characterized by sustainability, as it uses resources sparingly and is based on cold printing, which eliminates the need for post-processing.
With the current orders, Exentis has already delivered ten production systems to the USA this year. The company has only been active in this market for a year and is nevertheless exceeding its own expectations. The strong demand from various industries indicates that numerous additional projects and license agreements could arise in the coming years.
Subscribe to our Newsletter
3DPresso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.
